Filter posts

Is the Myriad Case Decision and/or the DOJ Brief TRIPS Compliant?

Judge Sweet seemed to dismiss Myriad’s constitutional taking and TRIPS claims by indicating: “Finally, Myriad’s suggestion that invalidating …

Trojan Gene Scientist: Risk from GE Salmon is Low

The Los Angeles Times ran an article on November 26 debunking the key argument of …

BIO's Comments on proposed PTO Humanitarian Technologies and Licensing Through the Intellectual Prop...

Here are the highlights from BIO’s recent submission on the proposed PTO “Request for Comments …

Recent Federal Register Notices

 A collection of Federal Register Notices dating back to November 5th.  Mainly for Small and …

The Wonders of Biotechnology: "Healthy" Chocolate!

Forget penicillin, space travel and the silicon chip. Science is on the verge of its …

AUTM Bayh-Dole 30th Anniversary Event

Association of University Technology Managers Press Release Deerfield, IL — December 12, 2010 will mark …

Working With A New Congress

Having experienced many election nights as a state legislator and Member of Congress, I still …

Update - Analysis of Therapeutic Discovery Project Awards

Here are the results from our recent analysis of the Therapeutic Discovery Project. (For additional …

Clinical Trial Success Rates - Recent Study from Tufts

Joseph DiMasi and his team at Tufts University published a paper earlier this year in …

IPO Update - November 11th, 2010

Today’s IPO from Complete Genomics (GNOM) brings the US biotech IPO list to 17 since …